• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度城市地区糖尿病视网膜病变的发病率与进展:桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究,15年随访

Incidence and Progression of Diabetic Retinopathy in Urban India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, 15yr Follow up.

作者信息

Raghu Keerthana, Surya R Janani, Rani Padmaja Kumari, Sharma Tarun, Raman Rajiv

机构信息

Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India.

Department of Biostatistics, National Institute of Epidemiology, Chennai, India.

出版信息

Ophthalmic Epidemiol. 2025 Aug;32(4):428-436. doi: 10.1080/09286586.2024.2419015. Epub 2024 Nov 12.

DOI:10.1080/09286586.2024.2419015
PMID:39531593
Abstract

To evaluate the 15 year incidence and progression of Diabetic Retinopathy (DR) and identify risk factors among Indian population. From a cross-sectional study of 1425 subjects, 911 participants took part in the 4-year follow-up. Out of these 911 participants, 140 returned for the 15-year follow-up, with baseline examinations conducted between 2003 and 2006, and subsequent follow-ups occurring from 2007 to 2011 and the current 15-year follow-up from 2018 to 2021. Of the 140 participants, 112 were eligible for analysis after excluding individuals with ungradable fundus photographs. The 15-year incidence of any diabetic retinopathy (DR) was 5%, with mild NPDR and moderate NPDR at 1.57% and 2.7%, respectively. Proliferative DR was observed in 0.71% of cases, while diabetic macular edema (DME) and sight-threatening diabetic retinopathy (STDR) rates were 0.48% and 1.10%, respectively. Age-standardized rates revealed a significant association with increasing age and incident any DR and STDR. DR progression over 15 years included 7.5% one-step and 1.75% two-step progressions, while regression was limited to 1.75% one-step regression. Multiple logistic regression analyses revealed that baseline duration of diabetes, systolic blood pressure, HbA1c levels, and the presence of anemia influenced the incidence of any DR, DME, and STDR. Smoking and higher HbA1c were identified as risk factors for one-step progression of DR. This study provides crucial insights into the long-term incidence, progression, and regression of DR among individuals with Type 2 diabetes in India.

摘要

评估印度人群中糖尿病视网膜病变(DR)的15年发病率及进展情况,并确定危险因素。在一项对1425名受试者的横断面研究中,911名参与者参加了为期4年的随访。在这911名参与者中,140人返回进行15年随访,基线检查于2003年至2006年进行,随后的随访分别在2007年至2011年以及当前的2018年至2021年15年随访期间进行。在这140名参与者中,排除眼底照片无法分级的个体后,112人符合分析条件。任何糖尿病视网膜病变(DR)的15年发病率为5%,轻度非增殖性糖尿病视网膜病变(NPDR)和中度NPDR的发病率分别为1.57%和2.7%。增殖性DR的发病率为0.71%,而糖尿病性黄斑水肿(DME)和威胁视力的糖尿病视网膜病变(STDR)的发病率分别为0.48%和1.10%。年龄标准化发病率显示,年龄增长与任何DR和STDR的发生之间存在显著关联。15年间DR的进展包括7.5%的一步进展和1.75%的两步进展,而逆转仅限于1.75%的一步逆转。多因素逻辑回归分析显示,糖尿病的基线病程、收缩压、糖化血红蛋白(HbA1c)水平以及贫血的存在会影响任何DR、DME和STDR的发病率。吸烟和较高的HbA1c被确定为DR一步进展的危险因素。本研究为印度2型糖尿病患者DR的长期发病率、进展和逆转情况提供了重要见解。

相似文献

1
Incidence and Progression of Diabetic Retinopathy in Urban India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study, 15yr Follow up.印度城市地区糖尿病视网膜病变的发病率与进展:桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究,15年随访
Ophthalmic Epidemiol. 2025 Aug;32(4):428-436. doi: 10.1080/09286586.2024.2419015. Epub 2024 Nov 12.
2
Incidence and Progression of Diabetic Retinopathy in Urban India: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS II), Report 1.印度城市地区糖尿病视网膜病变的发病率与进展:桑卡拉奈特拉亚糖尿病视网膜病变流行病学与分子遗传学研究(SN-DREAMS II),报告1
Ophthalmic Epidemiol. 2017 Oct;24(5):294-302. doi: 10.1080/09286586.2017.1290257. Epub 2017 Mar 23.
3
Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.糖尿病性黄斑水肿和增殖性糖尿病视网膜病变与心血管疾病的关联:一项系统评价和荟萃分析。
JAMA Ophthalmol. 2017 Jun 1;135(6):586-593. doi: 10.1001/jamaophthalmol.2017.0988.
4
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较:一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
5
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
6
Association between self-stigma and diabetic complications in Japanese people with type 2 diabetes: a cross-sectional study.日本2型糖尿病患者的自我污名与糖尿病并发症之间的关联:一项横断面研究。
BMJ Open. 2025 Jun 17;15(6):e095698. doi: 10.1136/bmjopen-2024-095698.
7
Incidence of diabetic retinopathy and predictors among adult patients with diabetes in central and southern Ethiopia: a multicentre retrospective cohort study.埃塞俄比亚中部和南部成年糖尿病患者糖尿病视网膜病变的发病率及预测因素:一项多中心回顾性队列研究
BMJ Open. 2025 Jan 21;15(1):e090916. doi: 10.1136/bmjopen-2024-090916.
8
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较:一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.
9
Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis.中国糖尿病视网膜病变的患病率、危险因素和负担:系统评价和荟萃分析。
J Glob Health. 2018 Jun;8(1):010803. doi: 10.7189/jogh.08.010803.
10
Prevalence of diabetes and diabetic retinopathy among adults aged 50 years and above in Nepal: a population-based cross-sectional survey.尼泊尔50岁及以上成年人中糖尿病和糖尿病视网膜病变的患病率:一项基于人群的横断面调查。
BMJ Open Ophthalmol. 2025 Jun 20;10(1):e002191. doi: 10.1136/bmjophth-2025-002191.